Why Choose Retatrutide?

Retatrutide represents the next generation of metabolic research peptides. Designed to target multiple pathways simultaneously, it goes beyond traditional compounds by engaging GLP-1, GIP, and glucagon receptors in a single formulation.

Researchers value Retatrutide for its potential to deliver more comprehensive metabolic effects, making it a powerful option for advanced studies in weight regulation and energy balance.

What Makes It Stand Out

  • Triple-Action Mechanism – Works across three key metabolic pathways
  • High Research Interest – Gaining attention in cutting-edge metabolic studies
  • Enhanced Potential – Designed for stronger and more complete outcomes compared to single-pathway peptides
  • Reliable Quality – Sourced for consistency and precision in laboratory environments
Skip to product information
1 of 1

Peptidesdxb

retatrutide gv pharmaceuticals 5x3mg

retatrutide gv pharmaceuticals 5x3mg

Regular price Dhs. 1,100.00 AED
Regular price Sale price Dhs. 1,100.00 AED
Sale Sold out
Quantity

The Future of Metabolic Research
Retatrutide represents the next evolution in peptide science. As the world’s first Triple Hormone Receptor Agonist, Retatrutide (LY3437943) goes beyond the dual-action of Tirzepatide by targeting three distinct metabolic pathways. Known in clinical circles as "Triple G," it targets GLP-1, GIP, and Glucagon receptors simultaneously, offering unprecedented potency for metabolic studies.

Overview:
This product is intended strictly for laboratory research use.

Specifications:
- Form: Lyophilized powder
- Storage: Store in a cool, dry environment

Description:
Manufactured under controlled conditions to ensure consistency and quality for research applications.

Disclaimer:
For research purposes only. Not for human consumption.

View full details

Talk about your brand

Share information about your brand with your customers. Describe a product, make announcements, or welcome customers to your store.